Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 13344
TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641399(CHEMBL5571044 | US20250325542, Compound CDD-2997)
Affinity DataKi:  530nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641399(CHEMBL5571044 | US20250325542, Compound CDD-2997)
Affinity DataKi:  530nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641394(CHEMBL5569256 | US20250325542, Compound CDD-2616)
Affinity DataKi:  900nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641394(CHEMBL5569256 | US20250325542, Compound CDD-2616)
Affinity DataKi:  900nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641398(CHEMBL5563227 | US20250325542, Compound CDD-2653)
Affinity DataKi:  1.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641398(CHEMBL5563227 | US20250325542, Compound CDD-2653)
Affinity DataKi:  1.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641393(CHEMBL5574673 | US20250325542, Compound CDD-2600)
Affinity DataKi:  1.60E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641393(CHEMBL5574673 | US20250325542, Compound CDD-2600)
Affinity DataKi:  1.60E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782508(US20250325542, Compound CDD-2998)
Affinity DataKi:  1.90E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641402(CHEMBL5575666 | US20250325542, Compound CDD-3061)
Affinity DataKi:  2.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641402(CHEMBL5575666 | US20250325542, Compound CDD-3061)
Affinity DataKi:  2.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641384(CHEMBL5573606 | US20250325542, Compound CDD-2376)
Affinity DataKi:  3.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641384(CHEMBL5573606 | US20250325542, Compound CDD-2376)
Affinity DataKi:  3.30E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782503(US20250325542, Compound CDD-2974)
Affinity DataKi:  3.50E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782510(US20250325542, Compound CDD-3059)
Affinity DataKi:  4.80E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641392(CHEMBL5566813 | US20250325542, Compound CDD-2511)
Affinity DataKi:  8.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782512(US20250325542, Compound CDD-3060)
Affinity DataKi:  8.10E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641392(CHEMBL5566813 | US20250325542, Compound CDD-2511)
Affinity DataKi:  8.10E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641389(CHEMBL5571065 | US20250325542, Compound CDD-2463)
Affinity DataKi:  8.50E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641389(CHEMBL5571065 | US20250325542, Compound CDD-2463)
Affinity DataKi:  8.50E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782511(US20250325542, Compound CDD-2906)
Affinity DataKi:  1.10E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641385(CHEMBL5571730 | US20250325542, Compound CDD-2335)
Affinity DataKi:  1.30E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782509(US20250325542, Compound CDD-2615)
Affinity DataKi:  1.40E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641391(CHEMBL5574500 | US20250325542, Compound CDD-2522)
Affinity DataKi:  1.70E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641391(CHEMBL5574500 | US20250325542, Compound CDD-2522)
Affinity DataKi:  1.70E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782507(US20250325542, Compound CDD-2567)
Affinity DataKi:  2.40E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782505(US20250325542, Compound CDD-2975)
Affinity DataKi:  2.50E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641400(CHEMBL5574991 | US20250325542, Compound CDD-2985)
Affinity DataKi:  2.90E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641400(CHEMBL5574991 | US20250325542, Compound CDD-2985)
Affinity DataKi:  2.90E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641401(CHEMBL5569720 | US20250325542, Compound CDD-3080)
Affinity DataKi:  4.30E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641401(CHEMBL5569720 | US20250325542, Compound CDD-3080)
Affinity DataKi:  4.30E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782504(US20250325542, Compound CDD-2602)
Affinity DataKi:  4.60E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782506(US20250325542, Compound CDD-2510)
Affinity DataKi:  6.00E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641397(CHEMBL5572012 | US20250325542, Compound CDD-2897)
Affinity DataKi:  7.10E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641397(CHEMBL5572012 | US20250325542, Compound CDD-2897)
Affinity DataKi:  7.10E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782513(US20250325542, Compound CDD-2920)
Affinity DataKi:  8.70E+4nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641396(CHEMBL5564357 | US20250325542, Compound CDD-2907)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641396(CHEMBL5564357 | US20250325542, Compound CDD-2907)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641395(CHEMBL5570954 | US20250325542, Compound CDD-2919)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641395(CHEMBL5570954 | US20250325542, Compound CDD-2919)
Affinity DataKi: >1.00E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641386(CHEMBL5574010 | US20250325542, Compound CDD-2350)
Affinity DataKi:  1.25E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641387(CHEMBL5569219 | US20250325542, Compound CDD-2373)
Affinity DataKi:  1.36E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782496(US20250325542, Compound CDD-2336)
Affinity DataKi:  1.44E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782500(US20250325542, Compound CDD-2395)
Affinity DataKi:  1.53E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM782499(US20250325542, Compound CDD-2371)
Affinity DataKi:  2.17E+5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641390(CHEMBL5575195 | US20250325542, Compound CDD-2508)
Affinity DataKi:  3.69E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641390(CHEMBL5575195 | US20250325542, Compound CDD-2508)
Affinity DataKi:  3.69E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent

TargetMetallo-beta-lactamase type 2(Pseudomonas aeruginosa (g-Proteobacteria))
Baylor College of Medicine

US Patent
LigandPNGBDBM50641388(CHEMBL5590878 | US20250325542, Compound CDD-2363)
Affinity DataKi:  3.97E+5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details US Patent